New York Assembly Bill 9010: Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

New York · 2025-2026 session

Status: Introduced

What it does

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

Latest action

PRINT NUMBER 9010B (2026-05-04)

See how A 9010 affects you on CapitolKey

Browse more bills · CapitolKey home